To further assess the potency of survivin small molecule antagonists to induce apoptotic cell death in NEC cell lines, we concentrated on compound YM155 exhibiting the highest efficacy even in nanomolar concentrations. The gene discussed is BIRC5; the disease is neuroendocrine carcinoma.